Related Experiment Video
Updated: Sep 14, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Hepcidin Isoforms in Chronic Obstructive Pulmonary Disease Compared with the General Population.
Ingrid Marie Hardang1,2, Jūratė Šaltytė Benth2,3, Morten K Moe1
1Department of Multidisciplinary Laboratory Medicine and Medical Biochemistry, Akershus University Hospital, Lørenskog, Norway.
Hepcidin isoforms are linked to inflammation and iron status but not COPD. Long-term oxygen treatment did not significantly alter these hepcidin levels in COPD patients.
Area of Science:
- Endocrinology
- Pulmonology
- Nephrology
Background:
- Hepcidin (Hep) regulates iron metabolism, with isoforms whose functions are unclear.
- COPD influences Hep production via inflammation and hypoxemia.
- This study investigated Hep isoforms in COPD patients.
Purpose of the Study:
- Assess Hep isoform concentrations in COPD.
- Explore associations between Hep isoforms and pathophysiological variables.
- Evaluate the effect of long-term oxygen treatment (LTOT) on Hep levels.
Main Methods:
- Measured Hep isoforms, inflammation markers, iron status, and pO2 in 84 COPD patients and 59 controls.
- Assessed baseline and 6-month follow-up data.
- Used multivariable and random-effects tobit regression for analysis.
Main Results:
- Hep isoforms were detected in 96% of participants; Hep25 was most common.
- All isoforms correlated with C-reactive protein and ferritin.
- Hep25/Hep24 associated with transferrin saturation; Hep24 with kidney function markers. No association with COPD or pO2.
- Hep25 and Hep24 levels decreased over 6 months.
Conclusions:
- Hep isoforms are linked to inflammation, iron status, and kidney function.
- Hep isoform concentrations are not directly associated with COPD.
- LTOT initiation did not significantly alter Hep isoform concentrations.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
08:17Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: